Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 747 across all filing types
Latest filing 2021-11-16 Call Transcript
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Updates
Call Transcript Classification · 95% confidence The document is an invitation to a conference call discussing the financial performance for the quarter and half-year ended September 30, 2021. It includes details such as date, time, dial-in numbers, and participants. There is no actual financial data or report content, only an announcement of the call event. This matches the definition of a Call Transcript (CT) document type, which includes full text transcripts of company conference calls or invitations to such calls. Confidence is high because the document explicitly states it is a conference call invitation for financial results discussion.
2021-11-16 English
Updates
Regulatory Filings
2021-11-16 English
Copy of Newspaper Publication
Regulatory Filings
2021-11-15 English
Updates
Regulatory Filings
2021-11-13 English
Investor Presentation
Regulatory Filings
2021-11-13 English
Change in Company Secretary/Compliance Officer
Regulatory Filings Classification · 100% confidence The document text is extremely short (59 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of any meaningful information, the document cannot be classified as a report or announcement type. It fits best as a Regulatory Filing (RNS) fallback category due to absence of specific content.
2021-11-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.